增强介质干细胞的存活率和回归能力,以提高肝脏疾病的细胞移植疗效

Shaoxiong Yu1,2,3, Saihua Yu1,2,3, Haiyan Liu1,2,3

  • 1The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, 350025, People's Republic of China.

PubMed
概括

改善肝病中介酶干细胞 (MSC) 治疗需要改善细胞移植. 像低氧原始化和基因修改等策略可以提高MSC的生存率和回归,从而提高末期肝病的治疗效率.